AAPL336.06+6.66 (+2.02%) ▲|ABBV263.55+0.26 (+0.10%) ▲|ABT99.64-1.31 (-1.30%) ▼|ACN183.20+6.08 (+3.43%) ▲|ADBE239.02+5.85 (+2.51%) ▲|AMAT510.62-1.39 (-0.27%) ▼|AMD605.90-1.67 (-0.27%) ▼|AMGN423.73+0.09 (+0.02%) ▲|AMT164.69-0.87 (-0.53%) ▼|AMZN251.17+4.50 (+1.82%) ▲|AVGO353.41-1.69 (-0.48%) ▼|AXP305.25-0.15 (-0.05%) ▼|BA186.76-0.93 (-0.49%) ▼|BAC54.53-0.43 (-0.78%) ▼|BKNG162.88+0.54 (+0.33%) ▲|BLK1,064.86-3.09 (-0.29%) ▼|BMY62.98+0.12 (+0.19%) ▲|BNY145.34-1.65 (-1.12%) ▼|BRK-B501.04-1.31 (-0.26%) ▼|C129.72-1.08 (-0.83%) ▼|CAT819.79-6.85 (-0.83%) ▼|CL86.32-0.14 (-0.16%) ▼|CMCSA21.85+0.25 (+1.13%) ▲|COF193.62-2.85 (-1.45%) ▼|COP126.31+0.87 (+0.69%) ▲|COST918.75-5.84 (-0.63%) ▼|CRM229.34+4.03 (+1.79%) ▲|CSCO107.94+1.00 (+0.94%) ▲|CVS86.13-0.97 (-1.11%) ▼|CVX206.77+2.39 (+1.17%) ▲|DE672.96-5.92 (-0.87%) ▼|DHR223.44-2.27 (-1.01%) ▼|DIS105.46+0.05 (+0.05%) ▲|DUK114.40+0.19 (+0.17%) ▲|EMR156.55-0.70 (-0.44%) ▼|FDX285.71-1.77 (-0.61%) ▼|GD332.57+0.23 (+0.07%) ▲|GE314.48-3.41 (-1.07%) ▼|GEV957.48-5.02 (-0.52%) ▼|GILD150.44-0.85 (-0.56%) ▼|GM77.26-3.21 (-3.99%) ▼|GOOG346.71+9.39 (+2.78%) ▲|GOOGL350.06+9.14 (+2.68%) ▲|GS904.40-11.84 (-1.29%) ▼|HD285.31-2.73 (-0.95%) ▼|HON210.86+0.73 (+0.35%) ▲|IBM219.61-0.38 (-0.17%) ▼|INTC119.49+3.56 (+3.07%) ▲|INTU273.37+5.34 (+1.99%) ▲|ISRG409.01-3.17 (-0.77%) ▼|JNJ267.13-0.45 (-0.17%) ▼|JPM332.49-2.49 (-0.74%) ▼|KO86.53-0.32 (-0.36%) ▼|LIN479.64+6.27 (+1.32%) ▲|LLY1,176.31-8.32 (-0.70%) ▼|LMT510.06-2.16 (-0.42%) ▼|LOW185.49-1.78 (-0.95%) ▼|LRCX326.83+2.97 (+0.92%) ▲|MA556.39-7.19 (-1.28%) ▼|MCD232.20-1.79 (-0.76%) ▼|MDLZ58.37-0.44 (-0.74%) ▼|MDT87.02-0.07 (-0.08%) ▼|META734.35-4.44 (-0.60%) ▼|MMM166.12-2.37 (-1.41%) ▼|MO67.71-1.01 (-1.48%) ▼|MRK146.76-2.53 (-1.69%) ▼|MS189.32-3.44 (-1.78%) ▼|MSFT518.72+9.76 (+1.92%) ▲|MU1,068.81+3.73 (+0.35%) ▲|NEE76.19+0.30 (+0.39%) ▲|NFLX69.87-0.44 (-0.62%) ▼|NKE35.41-0.44 (-1.21%) ▼|NOW134.09+4.15 (+3.19%) ▲|NVDA230.29+3.08 (+1.35%) ▲|ORCL137.63-0.16 (-0.11%) ▼|PEP127.68-1.02 (-0.79%) ▼|PFE28.85+0.13 (+0.45%) ▲|PG146.71-1.61 (-1.09%) ▼|PLTR188.57+1.60 (+0.86%) ▲|PM192.49-1.41 (-0.73%) ▼|QCOM184.13+0.03 (+0.02%) ▲|RTX186.48-0.47 (-0.25%) ▼|SBUX95.09-0.34 (-0.36%) ▼|SCHW98.38-0.73 (-0.73%) ▼|SO83.45-0.01 (-0.01%) ▼|SPG201.92-2.37 (-1.16%) ▼|T24.53+0.05 (+0.21%) ▲|TMO682.06+2.45 (+0.36%) ▲|TMUS162.81-0.17 (-0.10%) ▼|TSLA353.67+0.83 (+0.24%) ▲|TXN282.08+0.39 (+0.14%) ▲|UBER68.85-0.51 (-0.74%) ▼|UNH369.25-5.69 (-1.52%) ▼|UNP274.27+0.12 (+0.04%) ▲|UPS93.84-0.09 (-0.10%) ▼|USB57.79+0.19 (+0.33%) ▲|V361.50-4.38 (-1.20%) ▼|VZ45.96-0.02 (-0.05%) ▼|WFC80.15-0.34 (-0.42%) ▼|WMT105.26-1.55 (-1.45%) ▼|XOM164.30+2.95 (+1.83%) ▲|AAPL336.06+6.66 (+2.02%) ▲|ABBV263.55+0.26 (+0.10%) ▲|ABT99.64-1.31 (-1.30%) ▼|ACN183.20+6.08 (+3.43%) ▲|ADBE239.02+5.85 (+2.51%) ▲|AMAT510.62-1.39 (-0.27%) ▼|AMD605.90-1.67 (-0.27%) ▼|AMGN423.73+0.09 (+0.02%) ▲|AMT164.69-0.87 (-0.53%) ▼|AMZN251.17+4.50 (+1.82%) ▲|AVGO353.41-1.69 (-0.48%) ▼|AXP305.25-0.15 (-0.05%) ▼|BA186.76-0.93 (-0.49%) ▼|BAC54.53-0.43 (-0.78%) ▼|BKNG162.88+0.54 (+0.33%) ▲|BLK1,064.86-3.09 (-0.29%) ▼|BMY62.98+0.12 (+0.19%) ▲|BNY145.34-1.65 (-1.12%) ▼|BRK-B501.04-1.31 (-0.26%) ▼|C129.72-1.08 (-0.83%) ▼|CAT819.79-6.85 (-0.83%) ▼|CL86.32-0.14 (-0.16%) ▼|CMCSA21.85+0.25 (+1.13%) ▲|COF193.62-2.85 (-1.45%) ▼|COP126.31+0.87 (+0.69%) ▲|COST918.75-5.84 (-0.63%) ▼|CRM229.34+4.03 (+1.79%) ▲|CSCO107.94+1.00 (+0.94%) ▲|CVS86.13-0.97 (-1.11%) ▼|CVX206.77+2.39 (+1.17%) ▲|DE672.96-5.92 (-0.87%) ▼|DHR223.44-2.27 (-1.01%) ▼|DIS105.46+0.05 (+0.05%) ▲|DUK114.40+0.19 (+0.17%) ▲|EMR156.55-0.70 (-0.44%) ▼|FDX285.71-1.77 (-0.61%) ▼|GD332.57+0.23 (+0.07%) ▲|GE314.48-3.41 (-1.07%) ▼|GEV957.48-5.02 (-0.52%) ▼|GILD150.44-0.85 (-0.56%) ▼|GM77.26-3.21 (-3.99%) ▼|GOOG346.71+9.39 (+2.78%) ▲|GOOGL350.06+9.14 (+2.68%) ▲|GS904.40-11.84 (-1.29%) ▼|HD285.31-2.73 (-0.95%) ▼|HON210.86+0.73 (+0.35%) ▲|IBM219.61-0.38 (-0.17%) ▼|INTC119.49+3.56 (+3.07%) ▲|INTU273.37+5.34 (+1.99%) ▲|ISRG409.01-3.17 (-0.77%) ▼|JNJ267.13-0.45 (-0.17%) ▼|JPM332.49-2.49 (-0.74%) ▼|KO86.53-0.32 (-0.36%) ▼|LIN479.64+6.27 (+1.32%) ▲|LLY1,176.31-8.32 (-0.70%) ▼|LMT510.06-2.16 (-0.42%) ▼|LOW185.49-1.78 (-0.95%) ▼|LRCX326.83+2.97 (+0.92%) ▲|MA556.39-7.19 (-1.28%) ▼|MCD232.20-1.79 (-0.76%) ▼|MDLZ58.37-0.44 (-0.74%) ▼|MDT87.02-0.07 (-0.08%) ▼|META734.35-4.44 (-0.60%) ▼|MMM166.12-2.37 (-1.41%) ▼|MO67.71-1.01 (-1.48%) ▼|MRK146.76-2.53 (-1.69%) ▼|MS189.32-3.44 (-1.78%) ▼|MSFT518.72+9.76 (+1.92%) ▲|MU1,068.81+3.73 (+0.35%) ▲|NEE76.19+0.30 (+0.39%) ▲|NFLX69.87-0.44 (-0.62%) ▼|NKE35.41-0.44 (-1.21%) ▼|NOW134.09+4.15 (+3.19%) ▲|NVDA230.29+3.08 (+1.35%) ▲|ORCL137.63-0.16 (-0.11%) ▼|PEP127.68-1.02 (-0.79%) ▼|PFE28.85+0.13 (+0.45%) ▲|PG146.71-1.61 (-1.09%) ▼|PLTR188.57+1.60 (+0.86%) ▲|PM192.49-1.41 (-0.73%) ▼|QCOM184.13+0.03 (+0.02%) ▲|RTX186.48-0.47 (-0.25%) ▼|SBUX95.09-0.34 (-0.36%) ▼|SCHW98.38-0.73 (-0.73%) ▼|SO83.45-0.01 (-0.01%) ▼|SPG201.92-2.37 (-1.16%) ▼|T24.53+0.05 (+0.21%) ▲|TMO682.06+2.45 (+0.36%) ▲|TMUS162.81-0.17 (-0.10%) ▼|TSLA353.67+0.83 (+0.24%) ▲|TXN282.08+0.39 (+0.14%) ▲|UBER68.85-0.51 (-0.74%) ▼|UNH369.25-5.69 (-1.52%) ▼|UNP274.27+0.12 (+0.04%) ▲|UPS93.84-0.09 (-0.10%) ▼|USB57.79+0.19 (+0.33%) ▲|V361.50-4.38 (-1.20%) ▼|VZ45.96-0.02 (-0.05%) ▼|WFC80.15-0.34 (-0.42%) ▼|WMT105.26-1.55 (-1.45%) ▼|XOM164.30+2.95 (+1.83%) ▲|
23.7 C
New York
Wednesday, September 30, 2026

Tag: 1

newssourceFORcompanyinformationcontent1releasesmarket

METALLIS CLOSES $1,500,000 NON-BROKERED PRIVATE PLACEMENT

VANCOUVER, BC, June 20, 2025 /CNW/ - Metallis Resources Inc. (TSXV: MTS); (OTCQB: MTLFF), (FSE: 0CVM) (the "Company" or "Metallis") announces the closing of its...

Electromechanical Actuators in Aircraft Market worth $804.3 million by 2030 – Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., June 20, 2025 /PRNewswire/ -- The electromechanical actuators in aircraft market is projected to reach USD 804.3 million by 2030, growing from...

Electromechanical Actuators in Aircraft Market worth $804.3 million by 2030 – Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., June 20, 2025 /PRNewswire/ -- The electromechanical actuators in aircraft market is projected to reach USD 804.3 million by 2030, growing from...

Time Temperature Indicator Market to Reach $1.57 Billion by 2035, Growing at a CAGR of 6.2% from 2025–Exclusive Report by Meticulous Research®

Market Growth Driven by Cold Chain Expansion, IoT Integration, Regulatory Compliance Requirements, and Focus on Food Safety REDDING, Calif., June 20, 2025 /PRNewswire/ -- According to...

Time Temperature Indicator Market to Reach $1.57 Billion by 2035, Growing at a CAGR of 6.2% from 2025–Exclusive Report by Meticulous Research®

Market Growth Driven by Cold Chain Expansion, IoT Integration, Regulatory Compliance Requirements, and Focus on Food Safety REDDING, Calif., June 20, 2025 /PRNewswire/ -- According to...

Industrial Cleaning Solvents Market worth $1.55 billion by 2030 – Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., June 20, 2025 /PRNewswire/ -- The report "Industrial Cleaning Solvents Market by Application (General & Medical Device Cleaning, Metal Cleaners, Disinfectants), End-use Industry (Manufacturing...

Biomarkers and New Therapeutic Strategies to Better Treat Brain Cancer

INRS Professor receives $1.2M to advance glioblastoma research  LAVAL, QC, June 20, 2025 /CNW/ - Professor Maya Saleh, a world-renowned expert in immuno-oncology at the Institut national...

Industrial Cleaning Solvents Market worth $1.55 billion by 2030 – Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., June 20, 2025 /PRNewswire/ -- The report "Industrial Cleaning Solvents Market by Application (General & Medical Device Cleaning, Metal Cleaners, Disinfectants), End-use Industry (Manufacturing...

Ipsen receives positive CHMP opinion for Cabometyx® in previously treated advanced neuroendocrine tumors

PARIS, FRANCE, 20 June 2025 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for Cabometyx® (cabozantinib) for adult patients with unresectable or metastatic, well differentiated extra-pancreatic (epNET) and pancreatic (pNET) neuroendocrine tumors who have progressed following at least one prior systemic therapy other than somatostatin analogues. This recommendation is based on results from the CABINET Phase III trial presented at the European Society of Medical Oncology (ESMO) Congress 2024 and published in the New England Journal of Medicine.3,4 A final decision on the approval in the European Union is expected in the coming months.

Arkay Whisky, Gin, Rum & Vodka Zero Proof Ranked #1 in Sales on The Liquor Mall USA

MIAMI, June 20, 2025 /PRNewswire/ -- Arkay Beverages, the global pioneer in alcohol-free spirits, proudly announces that its flagship products - Arkay Zero Proof...

Cyberway: ‘AI Middle Platform + AI Agent’ Dual Driver, [CYBER AI] Wisdom Empowerment to Build Enterprise-level AI Brain

GUANGZHOU, China, June 20, 2025 /PRNewswire/ -- With the maturation of AI technology, its application in the FMCG sector holds enormous potential. Building private AI...

So-Young Announces Extension of Plan to Implement ADS Ratio Change

BEIJING, June 20, 2025 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the leading aesthetic treatment platform in China connecting consumers...

Bright Scholar Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee

CAMBRIDGE, England and FOSHAN, China, June 20, 2025 /PRNewswire/ -- Bright Scholar Education Holdings Limited ("Bright Scholar" or the "Company") (NYSE: BEDU), a global...

Gene Solutions Strengthens China Footprint with Strategic Partnerships in Precision Oncology

BEIJING, June 20, 2025 /PRNewswire/ -- Gene Solutions announces the signing of two strategic Memoranda of Understanding (MOUs) with ZaoDx and Xiong'an MagicBiotech Co., Ltd....

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTags1

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers